Educational only. Not medical advice. Invite-only research preview.No PHI. Do not share patient names or identifying information (HIPAA).
MytoIntelligence
All targets

Molecular target

Mineralocorticoid Receptor

Aldosterone receptor in the distal nephron. Antagonism (spironolactone, eplerenone) is the mechanism of K-sparing diuretics; also relevant in heart failure and primary hyperaldosteronism. Glycyrrhizin (in non-deglycyrrhizinated licorice) inhibits 11β-HSD2 → cortisol-mediated mineralocorticoid effects → potassium-wasting hypertension.

3 drugs act here1 plant reach it via their compounds

Educational use only. This page summarizes published research and traditional-use records for educational purposes. It does not diagnose, treat, cure, or prevent any disease. Do not start, stop, or change medications based on this information. Discuss any decisions about therapies — pharmaceutical or botanical — with a qualified clinician who knows your medical history.

No PHI / HIPAA notice: Do not share Protected Health Information (PHI) of any patient on this site — including names, dates of birth, addresses, MRNs, or any identifying information. Use abstract case framing only. Sharing PHI with non-covered entities risks HIPAA violation regardless of platform capability.

Pharmaceutical agents

Drugs that act on Mineralocorticoid Receptor

These medications have Mineralocorticoid Receptor among their molecular targets. Sharing a target is a mechanistic relationship — it does not make any plant below an alternative to, or substitute for, these drugs.

Botanical connections

Plants whose compounds act on Mineralocorticoid Receptor

Each plant below contains a named compound documented to act on Mineralocorticoid Receptor. The compound and the reason for the connection are shown on every edge — a shared mechanism, not a therapeutic equivalence.

  • Glycyrrhizin (glycyrrhizic acid)Triterpene saponin

    Inhibits 11β-HSD2, the enzyme that inactivates cortisol in the kidney — endogenous cortisol then activates the mineralocorticoid receptor, producing pseudo-aldosterone effects (hypertension, hypokalemia, sodium retention). This is a HIGH-impact pharmacological effect at chronic doses, NOT a benign 'tonic' action.

  • Glycyrrhetinic acid (active metabolite)Triterpene

    Active metabolite produced by gut hydrolysis of glycyrrhizin; carries the same pharmacology.

A shared molecular target shows how a botanical and a drug relate mechanistically. It is not evidence that one can replace the other. Educational summary only — discuss any medication decision with your clinician.